Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Penclomedine: phase I results in patients with solid tumors

June 24, 1997

PBR ligand-melphalan conjugate with promise for brain tumors

June 24, 1997

Medac launches Oncaspar in Germany

June 23, 1997

Taxotere now available in Japan for non-small cell lung and breast cancers

June 23, 1997

Matrix initiates phase II trial of IntraDose in primary liver cancer

June 23, 1997

Agouron's IND for anticancer agent approved

June 20, 1997

Sugen receives notices of allowance covering SU-101 for solid tumor treatment

June 19, 1997

NeoPharm begins phase I/II trial for liposome-encapsulated doxorubicin

June 18, 1997

Results from phase II trial with thalidomide for prostate cancer reported

June 18, 1997

Suntory prepares compounds for thrombocytopenia

June 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...